Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function

Heart

Volumn 94, Issue 9, 2008, Pages 1147-1153

  Yao, K ^a   Huang, R ^a,b   Qian, J ^a   Cui, J ^a   Ge, L ^a   Li, Y ^a   Zhang, F ^a   Shi, H ^a   Huang, D ^a   Zhang, S ^a   Sun, A ^a   Zou, Y ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE; THALLIUM 201;

ADULT; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CORONARY VESSELS; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 50249180324     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.137919     Document Type: Article

References (30)

1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Annu Rev Med 1995;46:455-66.
2. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remolding after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-7.
3. Mattichak SJ, Harjai KJ, Dutcher JR, et al. Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI study. J Interv Cardiol 2005;18:255-60.
4. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-76.
5. Saha M, Zbinden R, Redwood SR, et al. Stem cells to repair the broken heart: much ado about nothing? Heart 2006;92:1717-9.
6. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
7. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
8. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
9. Schachinger V, Erbs S, Elsasser A, et al. Intracoronary bone marrow derived progenitor cells in acute myocardial infarction. N Eng J Med 2006;355:1210-21.
10. Ge J, Li Y, Qian J, et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006;92:1764-7.
11. Britten MB, Abolmaali N, Assmus B, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003;108:2212-8.
12. Otterstad JE. Measuring left ventricular volume and ejection fraction with the biplane Simpson's method. Heart 2002;88:559-60.
13. Leor J, Gerecht S, Cohen S, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007;93:1278-84.
14. Zhang S, Guo J, Zhang P, et al. Long-term effects of bone marrow mononuclear cell transplantation on left ventricular function and remodeling in rats. Life Sci 2004;74:2853-64.
15. Nagaya N, Fujii T, Iwase T, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287:H2670-6.
16. Wang Y, Johnsen HE, Mortensen S, et al. Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart 2006;92:768-74.
17. Erbs S, Linke A, Schachinger V, et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients With acute myocardial infarction: the Doppler Substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial. Circulation 2007;116:366-74.
18. Wojakowski W, Kucia M, Kazmierski M, et al. Circulating stem/progenitor cells in stable ischemic heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart 2008;94:27-33.
19. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
20. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease. The IACT study. J Am Coll Cardiol 2005;46:1651-8.
21. Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells aftermyocardial infarction. N Engl J Med 2006;355:1222-32.
22. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302.
23. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.
24. Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004;351:1097-105.
25. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.
26. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001;7:430-6.
27. Meyer GP, Wollen KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006;113:1287-94.
28. Hamouda MS, Kassem HK, Salama M, et al. Evaluation of coronary flow reserve in hypertensive patients by dipyridamole transesophageal Doppler echocardiography. Am J Cardiol 2000;86:305-8.
29. Erdogan D, Gullu H, Caliskan M, et al. Coronary flow reserve in dipper and non-dipper hypertensive patients. Blood Pressure 2005;14:345-52.
30. Galderisi M, Cicala S, Caso P, et al. Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 2002;90:860-4.